Okay, Amgn is on the prowl will not be deterred, hey we will save 45% and offer Celldex..

66.00 per share. Not likely but quite possible, Comparing apples to apples Celldex pipeline, market cap is equal to or many, many times greater, even if most come to fruition and most meaning LEAVING ASIDE many additional applications, for example mid to high GPNMB in other areas than BC. Best Biotech out there. They save 45% from ONXX offer with potential twice or three times or more the value, easily.

Not far fetched at all. Celldex has been and still is significantly undervalued with potential Amgen should be looking for to enhance it's pipeline. $ 50-60 would be a very conservative easy offer to justify today that would have to be considered, but ultimately rejected. Celldex pps will be $240 (my analysis and prediction look back at old posts) by end 2016 and working back from that in broad strokes $120 in 2015, $60 in 2014 and $30 this year. This is the base-case and any excellent news moves the pps target timeline up. Selling here would leave way too much money on the table. Accumulating here will still be better than most other investments this year.

Trending Tickers

i

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.

Yahoo! Finance Worldwide

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.